Vir Biotechnology, Inc.
VIRNASDAQHealthcare● Active
$8.51
$-0.14(-1.61%)
Market Cap$1.4B
P/E Ratio—
52W High$11.66
52W Low$4.155
Vir Biotechnology, Inc.（VIR）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · VIR · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $68.56M | $74.20M | $86.18M | $1615.80M | $1095.41M |
| Cost of Revenue | $11.71M | $478.64M | $572.83M | $620.97M | $513.87M |
| Gross Profit | $56.85M | ($404.44M) | ($486.65M) | $994.83M | $581.54M |
| Gross Margin %(computed) | 82.92% | -545.03% | -564.69% | 61.57% | 53.09% |
| Operating Expenses | |||||
| R&D Expenses | $432.80M | $506.50M | $579.72M | $474.65M | $448.01M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $524.87M | $182.72M | $197.66M | $161.76M | $160.79M |
| Operating Income | ($468.02M) | ($587.16M) | ($684.30M) | $833.07M | $420.75M |
| Operating Margin %(computed) | -682.68% | -791.27% | -794.04% | 51.56% | 38.41% |
| Interest Income | $40.24M | $71.81M | $86.99M | $28.09M | $0.44M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($437.77M) | ($523.11M) | ($628.19M) | $754.28M | $549.80M |
| Income Tax Expense | $0.22M | ($1.15M) | ($13.08M) | $238.44M | $21.22M |
| Net Income | ($437.99M) | ($521.96M) | ($615.06M) | $515.84M | $528.58M |
| Net Margin %(computed) | -638.87% | -703.40% | -713.69% | 31.92% | 48.25% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.16 | $-3.83 | $-4.59 | $3.89 | $4.07 |
| Wtd Avg Shares | 138.52M | 136.25M | 134.13M | 132.61M | 129.88M |
| EBITDA | ($426.09M) | ($508.91M) | ($641.64M) | $839.85M | $426.56M |
| EBITDA Margin %(computed) | -621.52% | -685.82% | -744.53% | 51.98% | 38.94% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解Vir Biotechnology, Inc.
关于Vir Biotechnology, Inc.（VIR）损益表
Vir Biotechnology, Inc.（VIR）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，VIR实现营收$0.07B，毛利润$0.06B（毛利率82.92%），净利润($0.44B)（净利率-638.87%）。
常见问题
VIR · 4 问Vir Biotechnology, Inc.（VIR）2025财年营收为$0.07B，同比down7.6%。
VIR revenueVIR salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08